IndraLab

Statements

USP14 binds SPAG5. 2 / 2
| 1 1
reach
"Co‐IP assay demonstrated that in HG‐treated HPCs, SPAG5 was enriched in the precipitated products of anti‐USP14, and silencing SPAG5‐AS1 reduced such enrichment, with the input level of SPAG5 reduced and input level of USP14 unchanged (Figure 6D), indicating that SPAG5‐AS1 mediated the binding of USP14 to SPAG5."
31957155
sparser
"Co‐IP assay demonstrated that in HG‐treated HPCs, SPAG5 was enriched in the precipitated products of anti‐USP14, and silencing SPAG5‐AS1 reduced such enrichment, with the input level of SPAG5 reduced and input level of USP14 unchanged (Figure xref D), indicating that SPAG5‐AS1 mediated the binding of USP14 to SPAG5."
31957155